Species differences in N-glucuronidation.

Glucuronidation of amines has been shown to exhibit species differences in vitro and in vivo. Substrates for N-glucuronidation can be classified according to the chemical structures of the resulting glucuronides into two groups: compounds that form non-quaternary N-conjugates, and those that form the quaternary counterparts. For compounds of the former class-such as sulfonamides, arylamines, and alicyclic, cyclic, and heterocyclic amines-species differences appear to be less striking and are of a quantitative nature. No one common laboratory animal species used routinely in metabolism research (e.g. rat, mouse, dog, non-human primate, rabbit, and guinea pig) has been shown to be deficient in N-glucuronidation when all of the substrates studied and reported are taken into consideration. The ability of a species to form N-glucuronides is compound-dependent, although rabbit and guinea pig appear to exhibit the highest capacity for this bioconjugation among preclinical species. For tertiary amines, most notably the tricyclic antidepressant and antihistamine drugs, N-glucuronidation is commonly observed in non-human primates and man. There are examples, however, of quaternary glucuronidation occurring in lower animal species. In exploring species differences in amine conjugation in vivo, it is noted that the apparent absence of N-glucuronides in animal urine may not reflect the inability of that species to form such conjugates, since the N-glucuronides may be excreted in bile. Problems such as degradation or low recoveries commonly encountered in isolation and identification of in vivo metabolites further complicate the interpretation of data. Because of the wide range of pKa values exhibited by various classes of amines, caution also should be exercised for in vitro studies since incubation conditions for N-glucuronidation often are substrate- and species-dependent. Explanations for the species differences observed in N-glucuronidation appear to be emerging as rapid advances are made in the understanding of the glucuronosyltransferases at the molecular level. More information, however, remains to be gathered from the glucuronosyltransferase genes of animal species other than humans before a better understanding of species differences in N-glucuronidation can be achieved.

[1]  M. Green,et al.  Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[2]  R. Miller,et al.  Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[3]  G. Siest,et al.  A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. , 1994, Molecular Pharmacology.

[4]  G. Siest,et al.  N-glucuronidation reactions. III. Regioselectivity of N-glucuronidation of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole using human and rat recombinant UDP-glucuronosyltransferases stably expressed in V79 cells. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[5]  C. Fenselau,et al.  Quaternary ammonium-linked glucuronides of amitriptyline, imipramine, and chlorpromazine. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[6]  E. Boyland,et al.  The biochemistry of aromatic amines. II. The conversion of arylamines into arylsulphamic acids and arylamine-N-glucosiduronic acids. , 1957, The Biochemical journal.

[7]  K. Midha,et al.  N(+)-glucuronidation of aliphatic tertiary amines, a general phenomenon in the metabolism of H1-antihistamines in humans. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  M. Green,et al.  Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[9]  D. Schrenk,et al.  Consequences of 3-methylcholanthrene-type induction for the metabolism of 4-aminobiphenyl in isolated rat hepatocytes. , 1994, Carcinogenesis.

[10]  R. Adamson,et al.  The fate of sulphadimethoxine in primates compared with other species. , 1970, The Biochemical journal.

[11]  P. L. Jacobs,et al.  Biotransformation of mianserin in laboratory animals and man. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  S. R. Babu,et al.  Role of N-glucuronidation in benzidine-induced bladder cancer in dog. , 1992, Carcinogenesis.

[13]  R. T. Williams,et al.  Species differences in the metabolism of sulphadimethoxine. , 1968, The Biochemical journal.

[14]  D. Staiger,et al.  Structural assignment of an N-glucuronide metabolite of the phenylethanolamine N-methyltransferase (PNMT) inhibitor 1,2,3,4-tetrahydroisoquinoline-7-sulfonamide by 15N-NMR. , 1986, Biochemical pharmacology.

[15]  J. Caldwell The significance of phase II (conjugation) reactions in drug disposition and toxicity. , 1979, Life sciences.

[16]  M. Green,et al.  Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[17]  F. Schildberg,et al.  Metabolism of pimobendan in long-term human hepatocyte culture: in vivo-in vitro comparison. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.

[18]  R. Remmel,et al.  Isolation and characterization of a novel quaternary ammonium-linked glucuronide of lamotrigine. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[19]  T. Gillespie,et al.  Disposition and biotransformation of the antipsychotic agent olanzapine in humans. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[20]  F. Hsu,et al.  Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer. , 1991, Cancer research.

[21]  C. Fenselau,et al.  Synthesis of quaternary ammonium-linked glucuronides by rabbit hepatic microsomal UDP-glucuronyltransferase and analysis by fast-atom bombardment mass spectrometry. , 1982, Drug metabolism and disposition: the biological fate of chemicals.

[22]  K. Mizojiri,et al.  Quaternary ammonium glucuronide of croconazole in rabbits. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  B. Burchell,et al.  Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. , 1995, Life sciences.

[24]  D. J. Graham,et al.  The metabolism of nafimidone hydrochloride in the dog, primates and man. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[25]  R. Remmel,et al.  A quaternary ammonium glucuronide is the major metabolite of lamotrigine in guinea pigs. In vitro and in vivo studies. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[26]  C. Falany,et al.  Isolation and characterization of multiple forms of rat liver UDP-glucuronate glucuronosyltransferase. , 1986, The Biochemical journal.

[27]  J. Miller,et al.  Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. , 1977, Cancer research.

[28]  J. Magdalou,et al.  In vitro N-glucuronidation of SB 47436 (BMS 186295), a new AT1 nonpeptide angiotensin II receptor antagonist, by rat, monkey and human hepatic microsomal fractions. , 1994, The Journal of pharmacology and experimental therapeutics.

[29]  R. Miller,et al.  The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slices. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[30]  S. Smith,et al.  Disposition of nafimidone in rats. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[31]  P. Crooks,et al.  Characterization of the glucuronide conjugate of cotinine: a previously unidentified major metabolite of nicotine in smokers' urine. , 1992, Chemical research in toxicology.

[32]  D. J. Graham,et al.  The metabolism of imiloxan hydrochloride in healthy male volunteers. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[33]  G. Mulder,et al.  Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes. , 1994, Carcinogenesis.

[34]  L. Bertilsson,et al.  Formation of a quaternary N-glucuronide of amitriptyline in human liver microsomes. , 1987, Pharmacology & toxicology.

[35]  M A Butler,et al.  Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. , 1992, Environmental health perspectives.

[36]  B. Arison,et al.  Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man. , 1978, Drug metabolism and disposition: the biological fate of chemicals.

[37]  A. Guillouzo,et al.  Species differences in metabolism of ketotifen in rat, rabbit and man: demonstration of similar pathways in vivo and in cultured hepatocytes. , 1987, Life sciences.

[38]  R. Miller,et al.  N-glucuronidation reactions. II. Relative N-glucuronidation reactivity of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole in rat, monkey, and human hepatic microsomes. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[39]  J. Maguire,et al.  5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog. , 1982, Drug Metabolism And Disposition.

[40]  K. Midha,et al.  N(+)-glucuronidation of aliphatic tertiary amines in human: antidepressant versus antipsychotic drugs. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.

[41]  B. Arison,et al.  Human metabolism of cyproheptadine. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[42]  M. Tarbit,et al.  Characterization of a quaternary, N-glucuronide metabolite of the imidazole antifungal, tioconazole. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[43]  S. R. Babu,et al.  Benzidine glucuronidation in dog liver. , 1993, Carcinogenesis.

[44]  Y. Nakamura,et al.  Urinary metabolites of pinacidil. II. Species difference in the metabolism of pinacidil. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.

[45]  G. Siest,et al.  In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes. , 1992, The Journal of pharmacology and experimental therapeutics.

[46]  S. R. Babu,et al.  N-acetylbenzidine-N'-glucuronidation by human, dog and rat liver. , 1993, Carcinogenesis.

[47]  M. Green,et al.  N-glucuronidation of carcinogenic aromatic amines catalyzed by rat hepatic microsomal preparations and purified rat liver uridine 5'-diphosphate-glucuronosyltransferases. , 1987, Cancer research.

[48]  K. J. Donham,et al.  Formation and urinary excretion of cyproheptadine glucuronide in monkeys, chimpanzees, and humans. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[49]  B. Arison,et al.  Metabolism of cyclobenzaprine in the dog. , 1978, Drug Metabolism And Disposition.

[50]  P. Deutsch,et al.  Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[51]  R. Miller,et al.  N-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[52]  E. Vesell,et al.  Identification of radiolabeled metabolites of nicotine in rat bile. Synthesis of S-(-)-nicotine N-glucuronide and direct separation of nicotine-derived conjugates using high-performance liquid chromatography. , 1993, Journal of chromatography.

[53]  J. Bridges,et al.  Species differences in the metabolism and excretion of sulphasomidine and sulphamethomidine. , 1969, Biochemical Journal.

[54]  G. Siest,et al.  The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. , 1991, DNA and cell biology.

[55]  Y. Sugimoto,et al.  The involvement of the peripheral 5-HT2A receptor in peripherally administered serotonin-induced hyperglycemia in rats. , 1995, Life sciences.

[56]  K. Bock,et al.  N-glucuronide formation of carcinogenic aromatic amines in rat and human liver microsomes. , 1984, Biochemical pharmacology.